Recent News

• 02.05.2025 - Guggenheim SMID Cap Biotech Conference, New York
• 01.27.2025 - Tourmaline Bio to Present at the Guggenheim Securities SMID Cap Biotech Conference
• 01.10.2025 - Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker
• 12.10.2024 - Investor Day
• 12.10.2024 - Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day
• 12.06.2024 - Etzer Darout

Recent Filings

• 02.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.10.2024 - 8-K Current report
• 12.10.2024 - EX-99.1 EX-99.1